You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

M2951

Showing 1 - 25 of 75
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Nottingham (Ref (TF2), Evobrutinib MR-T1, Evobrutinib MR-T2)

Recruiting
  • Healthy
  • Ref (TF2)
  • +8 more
  • Nottingham, United Kingdom
    Quotient Clinical Ltd
Jul 11, 2022

Hepatic Impairment Trial in Kiel (M2951 (BTK inhibitor))

Completed
  • Hepatic Impairment
  • M2951 (BTK inhibitor)
  • Kiel, Germany
    CRS Clinical Research Services Kiel GmbH
Jul 9, 2021

Healthy Trial in Neu-Ulm (Evobrutinib, Carbamazepine)

Recruiting
  • Healthy
  • Neu-Ulm, Bavaria, Germany
    Nuvisan GmbH
Feb 9, 2022

Healthy Trial in Neu-Ulm (Evobrutinib, Digoxin, Metformin)

Completed
  • Healthy
  • Neu-Ulm, Germany
    Nuvisan GmbH
Jan 10, 2022

Relapsing-remitting Multiple Sclerosis Trial in Worldwide (Evobrutinib, Placebo, Tecfidera)

Active, not recruiting
Has Results
  • Relapsing-remitting Multiple Sclerosis
  • Blagoevgrad, Bulgaria
  • +55 more
May 4, 2021

Healthy Trial in Neu-Ulm (Midazolam, M2951)

Completed
  • Healthy
  • Neu-Ulm, Germany
    Nuvisan GmbH
Mar 22, 2021

Relapsing-remitting Multiple Sclerosis Trial in Rockland, Darmstadt (Evobrutinib, Avonex®, Avonex® matched Placebo)

Terminated
Has Results
  • Relapsing-remitting Multiple Sclerosis
  • Rockland, Massachusetts
  • +1 more
Jul 13, 2021

Relapsing-remitting Multiple Sclerosis Trial in Rockland, Darmstadt (Evobrutinib, Avonex®, Avonex® matched Placebo)

Terminated
Has Results
  • Relapsing-remitting Multiple Sclerosis
  • Rockland, Massachusetts
  • +1 more
Jul 13, 2021

Systemic Lupus Erythematosus Trial in Worldwide (Placebo, M2951)

Terminated
Has Results
  • Systemic Lupus Erythematosus
  • Placebo
  • M2951
  • Anniston, Alabama
  • +156 more
Mar 16, 2021

Healthy Trial in Groningen (Evobrutinib)

Completed
  • Healthy
  • Groningen, Netherlands
    PRA Health Sciences
Jul 3, 2020

Healthy Trial in Neu-Ulm (Evobrutinib)

Completed
  • Healthy
  • Neu-Ulm, Germany
    Nuvisan GmbH
Jul 3, 2020

Healthy Trial in Neu-Ulm (Evobrutinib)

Completed
  • Healthy
  • Neu-Ulm, Germany
    Nuvisan GmbH
Jul 8, 2020

Renal Impairment Trial in Darmstadt (Evobrutinib)

Completed
  • Renal Impairment
  • Darmstadt, Germany
    Please Contact the Merck KGaA Communication Center
May 15, 2019

Rheumatoid Arthritis Trial in Worldwide (M2591 25 mg QD, M2951 75 mg QD, M2951 50 mg BID)

Completed
Has Results
  • Rheumatoid Arthritis
  • M2591 25 mg QD
  • +3 more
  • Phoenix, Arizona
  • +97 more
Sep 4, 2020

Rheumatoid Arthritis Trial in Billerica, Darmstadt (Placebo, M2951)

Completed
Has Results
  • Rheumatoid Arthritis
  • Placebo
  • M2951
  • Billerica, Massachusetts
  • +1 more
Jun 18, 2018

Camrelizumab in Treatment of Advanced Non-squamous

Recruiting
  • Lung Cancer
  • Nantong, Jiangsu, China
    Department of Pharmacy, Affiliated Hospital of Nantong Universit
May 19, 2022

Relapsed/Refractory B Cell Malignancies, Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia

Active, not recruiting
  • Relapsed/Refractory B Cell Malignancies
  • +3 more
  • Columbus, Ohio
  • +17 more
Aug 18, 2022

Relapsing Multiple Sclerosis Trial in Worldwide (Evobrutinib, Placebo (match to Teriflunomide), Teriflunomide)

Active, not recruiting
  • Relapsing Multiple Sclerosis
  • Cullman, Alabama
  • +275 more
Nov 7, 2022

Relapsing Multiple Sclerosis Trial in Worldwide (Evobrutinib, Placebo (match to Teriflunomide), Teriflunomide)

Active, not recruiting
  • Relapsing Multiple Sclerosis
  • Mobile, Alabama
  • +278 more
Nov 7, 2022

Breast Cancer Trial in France, Netherlands (ddAC-CP-Olaparib, ddAC-mini CTC)

Recruiting
  • Breast Cancer
  • Marseille, France
  • +10 more
Oct 11, 2022

Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)

Recruiting
  • Non-Cystic Fibrosis Bronchiectasis
  • Brensocatib 10 mg
  • +2 more
  • Birmingham, Alabama
  • +416 more
Jan 24, 2023

Real-World Use of Ixazomib Citrate in People With Multiple

Recruiting
  • Multiple Myeloma
  • No Intervention
  • Anyang, Korea, Republic of
  • +20 more
Jun 15, 2022

Hepatitis C Infection, HIV Infection Trial in Brazil, Puerto Rico, United States (Glecaprevir/Pibrentasvir (G/P), Ribavirin

Recruiting
  • Hepatitis C Infection
  • HIV Infection
  • Glecaprevir/Pibrentasvir (G/P)
  • Ribavirin (RBV)
  • San Diego, California
  • +15 more
Dec 19, 2022

Solid Tumors Trial in Worldwide (Pembrolizumab, Standard of Care (SOC))

Recruiting
  • Solid Tumors
  • Tucson, Arizona
  • +374 more
Aug 22, 2022

Autism Spectrum Disorder Trial in Bloomington (Virtual reality active video gaming using Nintendo switch sports, Standard

Recruiting
  • Autism Spectrum Disorder
  • Virtual reality active video gaming using Nintendo switch sports
  • Standard physical therapy balance exercises
  • Bloomington, Indiana
    Indiana University Bloomington
Aug 29, 2023